Trial intelligence / Profile preview

ShenqiDihuang Decoction for Middle Stage Diabetic Kidney Disease

NCT03681249Phase 1Completed

Sponsor
Shanghai University of Traditional Chinese Medicine
Start
Nov 2018
Primary completion
Dec 2021
Modality
HM (Herbal Medicine)
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in diabetic kidney disease (DKD) comparing ShenqiDihuang Decoction with Placebo (2 arms). Primary endpoint: 24-Hour Urine Total Protein at 24 weeks. Started Nov 2018; status: completed.

02

Drugs

Shenqi Dihuang decoction
03

Conditions

diabetic kidney disease (DKD)

Beyond the preview

Go deeper on NCT03681249.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03681249.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call